#Japan #Tokyo #microbiome #HEM Pharma #Amway

Amway and HEM Pharma's Strategic Partnership for Personalized Health Solutions

The collaboration between HEM Pharma Japan and Amway Japan marks a significant step towards utilizing the gut microbiome for personalized health solutions in Japan. Based in Shibuya, Tokyo, HEM Pharma Japan aims to implement cutting-edge microbiome research into practical solutions to improve health lifespan. Their partnership with Amway Japan is a part of their strategy to leverage big data on gut microbiome to offer tailored health solutions to consumers.

HEM Pharma Inc., located in South Korea and known for its innovative microbiome analysis techniques, has established a strategic alliance with Amway, whose parent company is based in Michigan, USA. This partnership facilitates a collaborative effort focused on data collection and technological implementation, building a solid research foundation for microbiome data in Japan.

Traditionally, personalized health solutions relied heavily on DNA analysis. However, the shift towards utilizing the microbiome—an evolving ecosystem influenced by daily lifestyle choices—has gained traction as it provides a more dynamic approach to personalization. The gut microbiome acts as a modifiable health factor, offering the potential for more adaptive health interventions.

HEM Pharma has developed the proprietary simulation technology known as PMAS (Personalized Pharmaceutical Meta-Analytical Screening). This technology is pivotal in supporting individuals to live longer and healthier lives by facilitating the development of new personalized health solutions through microbiome data. Moreover, there's a growing interest in exploring the microbiome's role in diseases with unclear mechanisms, such as lifestyle-related illnesses, diabetes, dementia, and autism.

The crux of this initiative lies in accumulating vast amounts of data. The diversity of the microbiome among individuals necessitates extensive datasets to accurately capture its characteristics. By compiling and analyzing large-scale data, researchers can uncover previously obscured correlations and trends, enabling the creation of highly tailored personalized health solutions.

To date, HEM Pharma has collected over 95,000 microbiome samples, establishing one of the largest databases in the world. This achievement is attributed to long-term collaborations with local partners in South Korea. Now, through its relationship with Amway Japan, HEM Pharma can leverage Amway's strong customer base for quicker data accumulation and systematic feedback, which is crucial for enhancing the accuracy of the PMAS algorithms and expanding the database. Furthermore, the analysis of Japanese microbiome data will allow comparisons with South Korean data, evolving PMAS into a more globally relevant model accommodating diverse races and lifestyles.

In the future, HEM Pharma envisions commercializing personalized solutions using PMAS technology, leading to an exciting advancement in health care.

By leveraging the latest research in gut microbiomes, HEM Pharma aims to provide science-based proposals for lifestyle improvements, shaping the next generation of health solutions for consumers.

About HEM Pharma Japan

• - Company Name: HEM Pharma Japan Inc.
• - CEO: Yosep Ji
• - Location: 1-1-3 Shoto, Shibuya, Tokyo 150-0046, Japan
• - Establishment Date: January 6, 2025
• - Business Scope: Provision of personalized healthcare services based on microbiome analysis.

About HEM Pharma Inc.

HEM Pharma Inc. is a health care company specializing in gut microbiomes, providing customized health services using the PMAS technology, alongside platforms for developing live biotherapeutic products. They utilize advanced analytics, including multi-omics and microbiome analysis, within their products.

• - Company Name: HEM Pharma Inc.
• - Market: Kosdaq
• - CEO: Yosep Ji
• - Location: Suwon, Gyeonggi-do, South Korea
• - Establishment Date: December 30, 2016

About Amway

Amway, the world's number one direct selling company, is headquartered in Ada, Michigan, with operations in over 100 countries. They aim to support people in achieving a healthier and prosperous life, offering various daily-use products. Notable brands include Nutrilite, Artistry, and eSpring. Amway Japan has also engaged in community development projects, helping to support recovery efforts following the Great East Japan Earthquake and combating child poverty through initiatives like the Tomorrow HOPE Project.